Literature DB >> 14217253

IS POSTOPERATIVE WOUND INFECTION FOLLOWING SIMPLE INGUINAL HERNIORRHAPHY A PREDISPOSING CAUSE OF RECURRENT HERNIA?

F GLASSOW.   

Abstract

The significance of postoperative wound infection in simple inguinal herniorrhaphy was studied in a series of almost 26,000 simple inguinal herniorrhaphies. There was a recurrence rate of about 1% in uninfected cases and 4% in infected cases. The wound infection rate was 1.8%. Of about 2500 patients with recurrent inguinal hernia admitted to the Shouldice Hospital, Toronto, following an initial operation of elsewhere, about 4% gave a history of postoperative wound infection. Postoperative wound infection after simple inguinal herniorrhaphy increased the risk of a subsequent recurrent hernia about four times. However, in more than 95% of cases other etiological factors were responsible for the recurrence. No relation between infection and type of recurrent inguinal hernia subsequently developing was demonstrable.

Entities:  

Keywords:  INGUINAL HERNIA; SURGICAL WOUND INFECTION

Mesh:

Year:  1964        PMID: 14217253      PMCID: PMC1927544     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  3 in total

1.  Inguinal hernia in the female.

Authors:  F GLASSOW
Journal:  Surg Gynecol Obstet       Date:  1963-06

2.  Wound infections, surgical gloves and hands of operating personnel.

Authors:  E E SHOULDICE; C J MARTIN
Journal:  Can Med Assoc J       Date:  1959-10-15       Impact factor: 8.262

3.  Sinus Formation Following Infected Herniorrhaphy Incisions: A Study of Sinuses Occurring after the use of Silk only, Wire only or A Combination of the Two.

Authors:  E E Shouldice; F Glassow; N Black
Journal:  Can Med Assoc J       Date:  1961-03-18       Impact factor: 8.262

  3 in total
  8 in total

Review 1.  Elective inguinal hernia repair with mesh: is there a need for antibiotic prophylaxis?--A review.

Authors:  Seema Biswas
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

2.  Does topical rifampicin reduce the risk of surgical field infection in hernia repair?

Authors:  Şahin Kahramanca; Oskay Kaya; Cem Azılı; Bahadır Celep; Emre Gökce; Tevfik Küçükpınar
Journal:  Ulus Cerrahi Derg       Date:  2013-06-01

3.  Prophylactic antibiotic use in elective inguinal hernioplasty in a trauma center.

Authors:  Z Ergul; M Akinci; C Ugurlu; H Kulacoglu; K B Yilmaz
Journal:  Hernia       Date:  2011-09-18       Impact factor: 4.739

4.  Femoral hernia: review of 1,143 consecutive repairs.

Authors:  F Glassow
Journal:  Ann Surg       Date:  1966-02       Impact factor: 12.969

5.  Effect of single-dose prophylactic ampicillin and sulbactam on wound infection after tension-free inguinal hernia repair with polypropylene mesh: the randomized, double-blind, prospective trial.

Authors:  M A Yerdel; E B Akin; S Dolalan; A G Turkcapar; M Pehlivan; I E Gecim; E Kuterdem
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

6.  The role of antibiotic prophylaxis in prevention of wound infection after Lichtenstein open mesh repair of primary inguinal hernia: a multicenter double-blind randomized controlled trial.

Authors:  Theo J Aufenacker; Dirk van Geldere; Taco van Mesdag; Astrid N Bossers; Benno Dekker; Edo Scheijde; Roos van Nieuwenhuizen; Esther Hiemstra; John H Maduro; Jan-Willem Juttmann; Diederik Hofstede; Cunera T M van Der Linden; Dirk J Gouma; Maarten P Simons
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

7.  The role of antibiotic prophylaxis on wound infection after mesh hernia repair under local anesthesia on an ambulatory basis.

Authors:  Angel Celdrán; Octavio Frieyro; Juan C de la Pinta; José L Souto; Jaime Esteban; José M Rubio; José F Señarís
Journal:  Hernia       Date:  2003-09-20       Impact factor: 4.739

8.  Polypropylene mesh repair of incarcerated and strangulated hernias: a prospective clinical study.

Authors:  O Topcu; A Kurt; S Soylu; G Akgol; M Atabey; B C Karakus; C Aydin
Journal:  Surg Today       Date:  2012-11-07       Impact factor: 2.549

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.